Not all people with CLL have to have therapy. Even with all latest advancements, the iwCLL still recommends watchful observation for sufferers with asymptomatic disorder.86 This recommendation is based on at least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 The two trials https://link-alternatif-mbl7754322.blogthisbiz.com/39083199/about-link-alternatif-mbl77